Wholomics has appointed a Medical Science Liaison to support early clinical validation and real-world evidence generation across major healthcare systems in the UK and Europe.
The role will focus on building clinical engagement across key institutions, including the NHS and wider European healthcare networks, helping to generate the evidence needed to support adoption and long-term clinical integration.
As precision medicine and genomic technologies continue to evolve, the ability to establish strong clinical validation pathways is becoming increasingly important, not only for regulatory and commercial progression, but for demonstrating real-world impact within healthcare settings.
Wenham Carter supported the search, securing a candidate with the scientific credibility and stakeholder engagement experience needed to operate across clinical, research, and healthcare environments. The appointment strengthens Wholomics’ ability to translate innovation into practical clinical application and build the partnerships required for future growth.
